|
FDA Approval of New Valve Indications May Save Edwards Sales Projections
Edwards Lifesciences garnered FDA approval of an expanded indication for the Sapien heart valve Oct. 19, just ahead of the company’s announcement of 9 percent sales growth in the 2012 third quarter.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives